Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model

By sjmartinez • October 16, 2023

Iannone V, Babu AF, Lok J, Gómez-Gallego C, D'Auria G, Vazquez-Uribe R, Vaaben TH, Bongers M, Mikkonen S, Vaittinen M, Tikkanen I, Kettunen M, Klåvus A, Sehgal R, Kaminska D, Pihlajamaki J, Hanhineva K, El-Nezami H, Alexander Sommer MO, Kolehmainen M. Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model. Mol Metab. 2023 Oct 13:101823. doi: 10.1016/j.molmet.2023.101823. Epub ahead of print. PMID: 37839774.

Tags: aldafermin, Cardiology/Epi, genetically modified E. coli Nissle 1917, Metabolic dysfunction-associated steatotic liver disease, non-alcoholic fatty liver disease, non-targeted metabolomics, omics integration, Publications, Transcriptomics

Artificial intelligence in coronary CT angiography: transforming the diagnosis and risk stratification of atherosclerosis

Irannejad K, Mafi M, Krishnan S, Budoff MJ. Artificial intelligence in coronary CT angiography: transforming the diagnosis and risk stratification of atherosclerosis. Int J Cardiovasc[...]

Dietary control of peripheral adipose storage capacity through membrane lipid remodelling

Tol MJ, Shimanaka Y, Bedard AH, Sapia J, Cui L, Colaço-Gaspar M, Hofer P, Ferrari A, Qian K, Kennelly JP, Lee SD, Gao Y, Xiao[...]

Changing Career Focus: Owen Witte Talks with Caius Radu and Johannes Czernin About a Life Dedicated to Science and Discovery

Witte O, Radu C, Czernin J. Changing Career Focus: Owen Witte Talks with Caius Radu and Johannes Czernin About a Life Dedicated to Science and[...]